Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="KLIMEK, L" or (type exact bookEditor and editor="KLIMEK, L")

Add to list
- Journal Article
- A1
ARIA-Versorgungspfade für die Allergenimmuntherapie 2019 = 2019 ARIA Care pathways for allergen immunotherapy

J. Bousquet, O. Pfaar, A. Togias, H.J. Schünemann, I Ansotegui, N.G. Papadopoulos, I Tsiligianni, I Agache, JM anto, Claus Bachert (UGent) , et al.

(2019) ALLERGOLOGIE. 42(9). p.404-425
Add to list
- Journal Article
- A1
- open access
Guidance to 2018 good practice : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

J Bousquet, A Bedbrook, W Czarlewski, GL Onorato, S Arnavielhe, D Laune, E Mathieu-Dupas, J Fonseca, E Costa, O Lourenco, et al.

(2019) CLINICAL AND TRANSLATIONAL ALLERGY. 9.
Add to list
- Journal Article
- A1
Emerging roles of innate lymphoid cells in inflammatory diseases : clinical implications

I Kortekaas Krohn, MM Shikhagaie, K Golebski, JH Bernink, C Breynaert, B Creyns, Z Diamant, WJ Fokkens, Philippe Gevaert (UGent) , P Hellings, et al.

(2018) ALLERGY. 73(4). p.837-850
Add to list
- Journal Article
- A1
EAACI position paper on the standardization of nasal allergen challenges

J Augé, J Vent, I Agache, L Airaksinen, P Campo Mozo, A Chaker, C Cingi, S Durham, W Fokkens, Philippe Gevaert (UGent) , et al.

(2018) ALLERGY. 73(8). p.1597-1608
Add to list
- Journal Article
- A1
The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life : the MASK study

J Bousquet, S Arnavielhe, A Bedbrook, J Fonseca, M Morais Almeida, A Todo Bom, I Annesi-Maesano, D Caimmi, P Demoly, P Devillier, et al.

(2018) ALLERGY. 73(2). p.505-510
Add to list
- Journal Article
- A1
Treatment of allergic rhinitis using mobile technology with real world data : the MASK observational pilot study

J Bousquet, S Arnavielhe, A Bedbrook, G Alexis-Alexandre, M van Eerd, R Murray, GW Canonica, M Illario, E Menditto, G Passalacqua, et al.

(2018) ALLERGY. 73(9). p.1763-1774
Add to list
- Journal Article
- A1
- open access
Geolocation with respect to personal privacy for the Allergy Diary app : a MASK study

D Samreth, S Arnavielhe, F Ingenrieth, A Bedbrook, GL Onorato, R Murray, R Almeida, MA Mizani, J Fonseca, E Costa, et al.

(2018) WORLD ALLERGY ORGANIZATION JOURNAL. 11(1).
Add to list
- Journal Article
- A1
Daily allergic multimorbidity in rhinitis using mobile technology : a novel concept of the MASK study

J Bousquet, P Devillier, JM Anto, M Bewick, T Haahtela, S Arnavielhe, A Bedbrook, R Murray, M van Eerd, JA Fonseca, et al.

(2018) ALLERGY. 73(8). p.1622-1631
Add to list
- Journal Article
- A1
- open access
MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

J Bousquet, S Arnavielhe, A Bedbrook, M Bewick, D Laune, E Mathieu-Dupas, R Murray, GL Onorato, JL Pépin, R Picard, et al.

(2018) CLINICAL AND TRANSLATIONAL ALLERGY. 8.
Add to list
- Journal Article
- A1
Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

J Bousquet, I Agache, MR Aliberti, R Angles, I Annesi-Maesano, JM Anto, S Arnavielhe, E Asayag, E Bacci, A Bedbrook, et al.

(2018) ALLERGY. 73(1). p.77-92
Add to list
- Journal Article
- A1
Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology

PW Hellings, L Klimek, C Cingi, I Agache, C Akdis, Claus Bachert (UGent) , J Bousquet, P Demoly, Philippe Gevaert (UGent) , V Hox, et al.

(2017) ALLERGY. 72(11). p.1657-1665
Add to list
- Journal Article
- A1
Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study

J Bousquet, DP Caimmi, A Bedbrook, M Bewick, PW Hellings, P Devillier, S Arnavielhe, Claus Bachert (UGent) , KC Bergmann, GW Canonica, et al.

(2017) ALLERGY. 72(6). p.857-865
Add to list
- Journal Article
- A1
- open access
Work productivity in rhinitis using cell phones : the MASK pilot study

J Bousquet, M Bewick, S Arnavielhe, E Mathieu-Dupas, R Murray, A Bedbrook, DP Caimmi, O Vandenplas, PW Hellings, Claus Bachert (UGent) , et al.

(2017) ALLERGY. 72(10). p.1475-1484
Add to list
- Journal Article
- A1
EUFOREA Rhinology Research Forum 2016 : report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis

PW Hellings, CA Akdis, Claus Bachert (UGent) , J Bousquet, B Pugin, G Adriaensen, R Advani, I Agache, C Anjo, R Anmolsingh, et al.

(2017) RHINOLOGY. 55(3). p.202-210
Add to list
- Journal Article
- A1
- open access
CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis : a SUNFRAIL report

J Bousquet, GL Onorato, Claus Bachert (UGent) , M Barbolini, A Bedbrook, L Bjermer, J Correia de Sousa, NH Chavannes, AA Cruz, E De Manuel Keenoy, et al.

(2017) CLINICAL AND TRANSLATIONAL ALLERGY. 7.
Add to list
- Journal Article
- A1
Building bridges for innovation in ageing : synergies between action groups of the EIP on AHA

J Bousquet, M Bewick, A Cano, P Eklund, G Fico, N Goswami, NA Guldemond, D Henderson, MJ Hinkema, G Liotta, et al.

(2017) JOURNAL OF NUTRITION HEALTH & AGING. 21(1). p.92-104
Add to list
- Journal Article
- A1
- open access
Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

MA Calderon, P Demoly, T Casale, CA Akdis, Claus Bachert (UGent) , M Bewick, BM Bilò, B Bohle, S Bonini, A Bush, et al.

(2016) CLINICAL AND TRANSLATIONAL ALLERGY. 6.
Add to list
- Journal Article
- A1
- open access
ARIA 2016 : care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

J Bousquet, PW Hellings, I Agache, A Bedbrook, Claus Bachert (UGent) , KC Bergmann, M Bewick, C Bindslev-Jensen, S Bosnic-Anticevitch, C Bucca, et al.

(2016) CLINICAL AND TRANSLATIONAL ALLERGY. 6.
Add to list
- Journal Article
- A1
- open access
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

J Bousquet, J Farrell, G Crooks, P Hellings, EH Bel, M Bewick, NH Chavannes, J Correia de Sousa, AA Cruz, T Haahtela, et al.

(2016) CLINICAL AND TRANSLATIONAL ALLERGY. 6.
Add to list
- Conference Paper
- C3
MP29-02* provides effective AR symptom control in real life regardless of number of previous clinic visits : results from Germany

U Wahn, Claus Bachert (UGent) , JC Virchow, R Moesges, HC Kuhl and L Klimek

(2015) ALLERGY. 70(suppl. 101). p.499-499
Add to list
- Conference Paper
- C3
MP29-02* provides effective relief in real life in all patients regardless of ARIA-defined severity : results from Germany

L Klimek, JC Virchow, U Wahn, R Moesges, H-C Kuhl and Claus Bachert (UGent)

(2015) ALLERGY. 70(suppl. 101). p.503-503
Add to list
- Conference Paper
- C3
MP29-02* provides effective relief in real life in patients previously treated with mono- and multiple-therapy : results from Germany

L Klimek, JC Virchow, U Wahn, R Mösges, H-C Kuhl and Claus Bachert (UGent)

(2015) ALLERGY. 70(suppl. 101). p.503-503
Add to list
- Conference Paper
- C3
MP29-02* provides effective AR symptom control in real life in previous or potential treatment failure patients : results from Germany

JC Virchow, L Klimek, U Wahn, R Moesges, HC Kuhl and Claus Bachert (UGent)

(2015) ALLERGY. 70(suppl. 101). p.503-504
Add to list
- Conference Paper
- C3
MP29-02* provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany

Claus Bachert (UGent) , R Mösges, JC Virchow, U Wahn, HC Kuhl and L Klimek

(2015) ALLERGY. 70(suppl. 101). p.505-505
Add to list
- Journal Article
- A1
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

J Bousquet, HJ Schunemann, J Fonseca, B Samolinski, Claus Bachert (UGent) , GW Canonica, T Casale, AA Cruz, P Demoly, P Hellings, et al.

(2015) ALLERGY. 70(11). p.1372-1392
Add to list
- Journal Article
- A1
MP29-02 (Dymista®) : eine neue Behandlungsoption für die allergische Rhinitis

L Klimek, Claus Bachert (UGent) , M Wagenmann, J Ring and O Pfaar

(2014) ALLERGOLOGIE. 37(2). p.55-68
Add to list
- Conference Paper
- C3
Real-world effectiveness of a new allergic rhinitis therapy (MP29-02)

L Klimek, JC Virchow, U Wahn, R Moesges, U Munzel and Claus Bachert (UGent)

(2014) ALLERGY. 69(suppl. 99). p.322-322
Add to list
- Journal Article
- A1
Leitlinie 'Rhinosinusitis' Langfassung: S2-Leitlinie der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- un Hals-Chirurgie

BA Stuck, Claus Bachert (UGent) , P Federspil, W Hosemann, L Klimek, R Mösges, O Pfaar, C Rudack, H Sitter, M Wagenmann, et al.

(2012) HNO. 60(2). p.141-162
Add to list
- Journal Article
- A1
Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis

T Schäfer, M Schnoor, M Wagenmann, L Klimek and Claus Bachert (UGent)

(2011) RHINOLOGY. 49(3). p.272-280
Add to list
- Journal Article
- A1
Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis

R Mösges, Claus Bachert (UGent) , C Rudack, B Hauswald, L Klimek, J Spaeth, G Rasp, J Vent and K Hörmann

(2011) ADVANCES IN THERAPY. 28(3). p.238-249
Add to list
- Journal Article
- A1
Rhinosinusitis guidelines of the German society for otorhinolaryngology, head and neck surgery

BA STUCK, Claus Bachert (UGent) , P FEDERSPIL, W HOSEMANN, L KLIMEK, R MOSGES, O PFAAR, C RUDACK, H SITTER, M WAGENMANN, et al.

(2007) HNO. 55(10).
Add to list
- Miscellaneous
Present role of sublingual immunotherapy in allergic diseases

I Kleine-Tebbe, Claus Bachert (UGent) , KC Bergmann, T Bieber, R Brehler, F Friedrichs, T Fuchs, L Klimek, MV Kopp, U Lepp, et al.

(2007) ALLERGOLOGIE. 30(10). p.378-388
Add to list
- Journal Article
- A1
Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis

GW CANONICA, J BOUSQUET, G VAN HAMMEE, Claus Bachert (UGent) , SR DURHAM, L KLIMEK, J MULLOL and Paul Van Cauwenberge (UGent)

(2006) RESPIRATORY MEDICINE. 100(10). p.1706-1715
Add to list
- Book Chapter
Die nasale Provokationstestung

L Klimek, H Reichelmann, WW Schlenter and Claus Bachert (UGent)

(2004) Manuale allergologikum.
Add to list
- Journal Article
- A1
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

Claus Bachert (UGent) , J BOUSQUET, GW CANONICA, SR DURHAM, L KLIMEK, J MULLOL, Paul Van Cauwenberge (UGent) and G VAN HAMMEE

(2004) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 114(4). p.838-844
Add to list
- Journal Article
- A1
Application of the nasal provocation test on diseases of the upper airways - Position paper of the German Society for Allergology and Clinical Immunology (ENT section) in cooperation with the working team for clinical immunology

H RIECHELMANN, Claus Bachert (UGent) , O GOLDSCHMIDT, B HAUSWALD, L KLIMEK, WW SCHLENTER, AJ TASMAN and M WAGENMANN

(2003) LARYNGO-RHINO-OTOLOGIE. 82(3). p.183-188
Add to list
- Journal Article
- A1
Guidelines of the DGAI on allergic rhinoconjunctivitis

Claus Bachert (UGent) , U BORCHARD, B WEDI, L KLIMEK, G RASP, H RIECHELMANN, G SCHULTZE-WERNINGHAUS, U WAHN and J RING

(2003) ALLERGOLOGIE. 26(4). p.147-162
Add to list
- Book Chapter
Therapie mit inhalativen Glukokortikoiden

L KLIMEK and Claus Bachert (UGent)

(2002) Allergische Entzündungen. p.150-172
Add to list
- Journal Article
- A2
Steroid sprays in non-infectious rhinitis and sinusitis. Proper and regular spraying does not damage the nasal mucosa.

L KLIMEK, Claus Bachert (UGent) and K HORMANN

(2002) M M W Fortschritte der Medizin. 144(10). p.41-43
Add to list
- Journal Article
- A1
Nasal provocation tests in diseases of the upper airways.

H RIECHELMANN, Claus Bachert (UGent) , O GOLDSCHMIDT, B HAUSWALD, L KLIMEK, WW SCHLENTER, AJ TASMAN and M WAGENMANN

(2002) ALLERGOLOGIE. 25(9). p.489-496
Add to list
- Journal Article
- A1
Current aspects of nasal glucocorticosteroid therapy.

L KLIMEK and Claus Bachert (UGent)

(2000) HNO. 48(7). p.544-555

ARIA-Versorgungspfade für die Allergenimmuntherapie 2019 = 2019 ARIA Care pathways for allergen immunotherapy

Guidance to 2018 good practice : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

Emerging roles of innate lymphoid cells in inflammatory diseases : clinical implications

EAACI position paper on the standardization of nasal allergen challenges

The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life : the MASK study

Treatment of allergic rhinitis using mobile technology with real world data : the MASK observational pilot study

Geolocation with respect to personal privacy for the Allergy Diary app : a MASK study

Daily allergic multimorbidity in rhinitis using mobile technology : a novel concept of the MASK study

MASK 2017 : ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - EIP on AHA Twinning Reference Site (GARD research demonstration project)

Non-allergic rhinitis : position paper of the European Academy of Allergy and Clinical Immunology

Pilot study of mobile phone technology in allergic rhinitis in European countries : the MASK-rhinitis study

Work productivity in rhinitis using cell phones : the MASK pilot study

EUFOREA Rhinology Research Forum 2016 : report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis : a SUNFRAIL report

Building bridges for innovation in ageing : synergies between action groups of the EIP on AHA

Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

ARIA 2016 : care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

MP29-02* provides effective AR symptom control in real life regardless of number of previous clinic visits : results from Germany

MP29-02* provides effective relief in real life in all patients regardless of ARIA-defined severity : results from Germany

MP29-02* provides effective relief in real life in patients previously treated with mono- and multiple-therapy : results from Germany

MP29-02* provides effective AR symptom control in real life in previous or potential treatment failure patients : results from Germany

MP29-02* provides effective AR symptom control in real life in all patient types regardless of predominant nasal symptom or presence of ocular symptoms: results from Germany

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

MP29-02 (Dymista®) : eine neue Behandlungsoption für die allergische Rhinitis

Real-world effectiveness of a new allergic rhinitis therapy (MP29-02)

Leitlinie 'Rhinosinusitis' Langfassung: S2-Leitlinie der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- un Hals-Chirurgie

Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis

Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis

Rhinosinusitis guidelines of the German society for otorhinolaryngology, head and neck surgery

Present role of sublingual immunotherapy in allergic diseases

Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis

Die nasale Provokationstestung

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

Application of the nasal provocation test on diseases of the upper airways - Position paper of the German Society for Allergology and Clinical Immunology (ENT section) in cooperation with the working team for clinical immunology

Guidelines of the DGAI on allergic rhinoconjunctivitis

Therapie mit inhalativen Glukokortikoiden

Steroid sprays in non-infectious rhinitis and sinusitis. Proper and regular spraying does not damage the nasal mucosa.

Nasal provocation tests in diseases of the upper airways.

Current aspects of nasal glucocorticosteroid therapy.